BioSyent (RX) News Today → Write this ticker symbol down… (From StocksToTrade) (Ad) Free RX Stock Alerts C$9.32 +0.07 (+0.76%) (As of 05:13 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 26 at 3:06 PM | finance.yahoo.comBioSyent (CVE:RX) Could Be A Buy For Its Upcoming DividendMay 24, 2024 | americanbankingnews.comEquities Analysts Set Expectations for BioSyent Inc.'s FY2024 Earnings (CVE:RX)May 23, 2024 | marketbeat.comBloom Burton Comments on BioSyent Inc.'s FY2024 Earnings (CVE:RX)BioSyent Inc. (CVE:RX - Free Report) - Investment analysts at Bloom Burton boosted their FY2024 EPS estimates for shares of BioSyent in a research note issued to investors on Tuesday, May 21st. Bloom Burton analyst D. Martin now expects that the company will earn $0.55 per share for the year, upMay 23, 2024 | americanbankingnews.comBloom Burton Analysts Raise Earnings Estimates for BioSyent Inc. (CVE:RX)May 22, 2024 | marketbeat.comQ2 2024 EPS Estimates for BioSyent Inc. Boosted by Analyst (CVE:RX)BioSyent Inc. (CVE:RX - Free Report) - Equities research analysts at Bloom Burton upped their Q2 2024 EPS estimates for BioSyent in a research note issued on Tuesday, May 21st. Bloom Burton analyst D. Martin now anticipates that the company will earn $0.13 per share for the quarter, up from theirMay 21, 2024 | finance.yahoo.comBioSyent (CVE:RX) Has Affirmed Its Dividend Of CA$0.045May 18, 2024 | marketbeat.comBioSyent (CVE:RX) Stock Passes Above Fifty Day Moving Average of $8.59BioSyent (CVE:RX) Stock Crosses Above 50-Day Moving Average of $8.59May 10, 2024 | marketbeat.comBioSyent (RX) Scheduled to Post Quarterly Earnings on ThursdayBioSyent (CVE:RX) will be releasing earnings after the market closes on Thursday, May 16, Zacks reports.May 10, 2024 | finance.yahoo.comIncreases to CEO Compensation Might Be Put On Hold For Now at BioSyent Inc. (CVE:RX)May 9, 2024 | msn.comAMD RDNA 4: Everything we know about the RX 8000 seriesMay 9, 2024 | insidertrades.comInsider Buying: BioSyent Inc. (CVE:RX) Insider Purchases 5,100 Shares of StockApril 16, 2024 | finanznachrichten.deBioSyent Inc.: BioSyent Announces Extension of RepaGyn and Proktis-M AgreementApril 4, 2024 | finance.yahoo.comBioSyent Inc.'s (CVE:RX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?April 3, 2024 | markets.businessinsider.comFeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive YearMarch 21, 2024 | finanznachrichten.deBioSyent Inc.: BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023March 16, 2024 | uk.investing.comEarnings call: BioSyent Inc. reports robust growth in Q4 and FY 2023February 21, 2024 | markets.businessinsider.comBioSyent Named to 2024 TSX Venture 50February 17, 2024 | seekingalpha.comRX:CA BioSyent Inc.February 16, 2024 | marketbeat.comBioSyent (CVE:RX) Stock Price Crosses Above Fifty Day Moving Average of $8.73BioSyent (CVE:RX) Stock Crosses Above 50 Day Moving Average of $8.73February 8, 2024 | marketbeat.comBioSyent (CVE:RX) Share Price Crosses Below 50 Day Moving Average of $8.70BioSyent (CVE:RX) Shares Cross Below 50-Day Moving Average of $8.70February 6, 2024 | markets.businessinsider.comBioSyent Declares First Quarter 2024 DividendNovember 24, 2023 | finance.yahoo.comIs It Smart To Buy BioSyent Inc. (CVE:RX) Before It Goes Ex-Dividend?November 20, 2023 | finance.yahoo.comBioSyent Announces the Availability of Gelclair® in CanadaNovember 20, 2023 | markets.businessinsider.comBloom Burton Believes Biosyent (RX) Won’t Stop HereNovember 16, 2023 | finance.yahoo.comBioSyent Releases Q3 and YTD 2023 Financial ResultsNovember 15, 2023 | markets.businessinsider.comBioSyent Declares Fourth Quarter 2023 DividendOctober 23, 2023 | es-us.finanzas.yahoo.comInvestors in BioSyent (CVE:RX) have seen returns of 21% over the past yearOctober 18, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc flat on Tuesday (RX)October 18, 2023 | theglobeandmail.comBioSyent Launches "menopauseinformation.ca" on World Menopause DayAugust 31, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc flat on Wednesday (RX)August 26, 2023 | finance.yahoo.comWhy You Might Be Interested In BioSyent Inc. (CVE:RX) For Its Upcoming DividendAugust 24, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of BioSyent Inc. (CVE:RX)August 23, 2023 | finanznachrichten.deBioSyent Inc.: BioSyent Releases Q2 and H1 2023 Financial ResultsAugust 22, 2023 | markets.businessinsider.comBioSyent Declares Third Quarter 2023 DividendAugust 8, 2023 | finance.yahoo.comBioSyent Launches Inofolic® for Women with Polycystic Ovary Syndrome (PCOS)July 18, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc down on Monday (RX)July 6, 2023 | finance.yahoo.comBioSyent Pharma to Introduce Gelclair® at AHNS 11th International Conference on Head and Neck CancerJune 20, 2023 | finance.yahoo.comBioSyent Announces Long-term Extension of Cathejell® AgreementMay 31, 2023 | finance.yahoo.comBioSyent Announces Approval of New ProductMay 26, 2023 | finanznachrichten.deBioSyent Inc.: BioSyent Releases Financial Results for Q1 2023May 26, 2023 | finance.yahoo.comBioSyent Releases Financial Results for Q1 2023May 25, 2023 | uk.finance.yahoo.comBioSyent Declares Second Quarter 2023 DividendMay 14, 2023 | uk.news.yahoo.comInvesting in BioSyent (CVE:RX) three years ago would have delivered you a 88% gainMay 3, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc up on Tuesday (RX)April 29, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc down on Friday (RX)April 28, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc down on Thursday (RX)April 19, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc down on Tuesday (RX)April 18, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc up on Monday (RX)April 15, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc up on Friday (RX)April 13, 2023 | theglobeandmail.comClosing Bell: Biosyent Inc up on Wednesday (RX) Get BioSyent News Delivered to You Automatically Sign up to receive the latest news and ratings for RX and its competitors with MarketBeat's FREE daily newsletter. Email Address Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything. Discover the #1 company leading this revolution RX Media Mentions By Week RX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RX News Sentiment▼0.690.78▲Average Medical News Sentiment RX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RX Articles This Week▼100▲RX Articles Average Week Get BioSyent News Delivered to You Automatically Sign up to receive the latest news and ratings for RX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Organigram News Cardiol Therapeutics News Cipher Pharmaceuticals News HLS Therapeutics News Decibel Cannabis News Charlotte's Web News MediPharm Labs News Medicure News Indiva News Willow Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:RX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBitcoin’s Biggest Year YetParadigm PressWrite this ticker symbol down…StocksToTradeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
